RAPT THERAPEUTICS INC

CUSIP: 75382E109 Class: Common Stock

Euclidean Capital LLC's Holding History (CIK: 0001825034)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 657,899 Value ($000) $803 Avg Close Range
Q4 2024
Shares 657,899 Value ($000) $1,039 Avg Close Range
Q3 2024
Shares 657,899 Value ($000) $1,322 Avg Close Range
Q2 2024
Shares 657,899 Value ($000) $2,007 Avg Close Range
Q1 2024
Shares 657,899 Value ($000) $5,908 Avg Close Range
Q4 2023
Shares 657,899 Value ($000) $16,349 Avg Close Range
Q3 2023
Shares 657,899 Value ($000) $10,934 Avg Close Range
Q2 2023
Shares 571,233 Value ($000) $10,682 Avg Close Range
Q1 2023
Shares 432,900 Value ($000) $7,944 Avg Close Range
Q4 2022
Shares 432,900 Value ($000) $8,571 Avg Close Range
Q3 2022
Shares 432,900 Value ($000) $10,416 Avg Close Range
Q2 2022
Shares 432,900 Value ($000) $7,900 Avg Close Range
Q1 2022
Shares 432,900 Value ($000) $9,519 Avg Close Range
Q4 2021
Shares 432,900 Value ($000) $15,900 Avg Close Range
Q3 2021
Shares 635,177 Value ($000) $19,722 Avg Close Range
Q2 2021
Shares 735,801 Value ($000) $23,391 Avg Close Range
Q1 2021
Shares 735,801 Value ($000) $16,335 Avg Close Range
Q4 2020
Shares 735,801 Value ($000) $14,532 Avg Close Range